Product Name | MF | CAS | Details |
---|
2-Hydroxy-4-(methoxymethyl)-6-methylpyridine-3-carbonitrile | C9H10N2O2 | 6339-38-4 | Details |
5-Chlorobenzene-1,3-diol | C6H5ClO2 | 52780-23-1 | Details |
CEA protein (in TRIS) | Details |
1-[(Trimethylsilyl)ethynyl]-1,2-benziodoxol-3(1H)-one | C12H13IO2Si | 181934-29-2 | Details |
1-Methyl-2,3-dihydro-1H-indene-1-carboxylic acid | C11H12O2 | 33223-78-8 | Details |
2-(4-Nitrophenoxy)ethanol | C8H9NO4 | 16365-27-8 | Details |
N,N-Diethyl-5-methyl-[1,2,4]triazolo[5,1-b]pyrimidin-7-amine | C10H15N5 | 15421-84-8 | Details |
GRHL2 Blocking Peptide | Details |
2-(4-(3-(2-(Trifluoromethyl)-10H-phenothiazin-10-yl)piperazin-1-yl)ethyl undecanoate | C33H46F3N3O2S | 13220-06-9 | Details |
Methoxy(dimethyl)-n-octylsilane | C11H26OSi | 93804-29-6 | Details |
H-Arg-Leu-Leu-Phe-Thr-NH2 | C31H53N9O6 | 447408-68-6 | Details |
6-bromo-5-fluoroindoline-2,3-dione | C8H3BrFNO2 | 1374208-41-9 | Details |
5-(2-Methoxyethyl)-1,3-benzoxazol-2-amine | C10H12N2O2 | 1251137-62-8 | Details |
3-Fluoro-5-nitrotoluene | C7H6FNO2 | 499-08-1 | Details |
MIPT3 antibody | Details |
1-[4-(Aminomethyl)phenyl]ethan-1-amine dihydrochloride | C9H15ClN2 | 1461714-89-5 | Details |
Poly(ethylene glycol) diglycidyl ether, MW500 | (C3H5ClO.(C2H4O)nH2O)x | 72207-80-8 | Details |
(3-(2-chlorophenyl)-5-methylisoxazol-4-yl)-N-(3-(phenylmethoxy)(2-pyridyl))formamide | C23H18ClN3O3 | 1022601-39-3 | Details |
rac-[(1R,2R)-2-(3-Methoxyphenyl)cyclopropyl]methanamine hydrochloride | C11H16ClNO | 1142815-95-9 | Details |
9,10-Dichloroanthracene | C14H8Cl2 | 605-48-1 | Details |
N,N-Bis(2-hydroxyethyl)acetamide | C6H13NO3 | 7435-67-8 | Details |
Methyl 5-(aminomethyl)tetrahydrofuran-2-carboxylate hydrochloride | C7H14ClNO3 | 1304126-25-7 | Details |
3'-Azido-3'-deoxy-5-fluorocytidine | C9H11FN6O4 | 2095417-18-6 | Details |
(2,3-Dihydro-1H-inden-2-yl)methanol | C10H12O | 5445-45-4 | Details |
5-o-TBDMS-DA | C16H27N5O3Si | 51549-30-5 | Details |
3-Azabicyclo[3.2.2]nonane HCl | C8H16ClN | 5597-41-1 | Details |
1-[(4-Chlorophenyl)methoxy]-4-(3-chloroprop-1-yn-1-yl)benzene | C16H12Cl2O | 1178666-08-4 | Details |
G250.A2 | C45H72N14O12 | Details |
PRKCB1 Blocking Peptide | Details |
(S)-Patulin methyl ether | C8H8O4 | 123251-09-2 | Details |
(1S,3S)-3-Aminocyclohexanol hydrochloride | C6H14ClNO | 2377847-94-2 | Details |
NGRN antibody | Details |
Cyclo(Tyr-Phe) | C18H18N2O3 | 5147-17-1 | Details |
NGA4 N-Glycan | C66H110N6O46 | 385767-06-6 | Details |
3,6-Bis(1,1-dimethylethyl)-10-phenyl-9-(2,4,6-trimethylphenyl)-acridinium tetrafluoroborate | C36H40BF4N | 1810004-87-5 | Details |
7-Methoxy-1H-indole-2-carboxylic acid | C10H9NO3 | 24610-33-1 | Details |
2'-Deoxy-5'-O-DMT-2'-fluorouridine 3'-O-succinate triethylammonium salt | C34H32FN2O10.C6H16N | Details |
(1-(4-Diethylamino)phenyl)-2-nitroethene | C12H16N2O2 | 147764-76-9 | Details |
Naphthol AS-MX | C19H17NO2 | 92-75-1 | Details |
LYRM1 antibody | Details |
LEAP-2 (38-77) (Human) | Details |
2'-Deoxy-2'-fluoroadenosine-5'-triphosphate sodium salt - 100mM aqueous solution | Details |
N-(2-indol-3-ylethyl)(2-(4-methylphenylthio)(3-pyridyl))formamide | C23H21N3OS | 1119391-57-9 | Details |
Imidaprilat benzyl ester, (carbonylimidazolidine)tert-butyl ester | C29H37N3O6 | 89460-20-8 | Details |
2-Oxo-1H,2H,3H-pyrrolo[2,3-b]pyridine-4-carboxylic acid | C8H6N2O3 | 1190310-95-2 | Details |
Recombinant Human Apolipoprotein E3 | Details |
1,2,4-Benzenetriol technical grade | C6H6O3 | 533-73-3 | Details |
3-Amino-4-(2,4,5-trifluorophenyl)butanoic acid hydrochloride | C10H11ClF3NO2 | 1909337-07-0 | Details |
Octadecylthioethyl 4-O-(a-D-galactopyranosyl)-b-D-galactopyranoside | C32H62O11S | 87019-34-9 | Details |
4-(tert-Butyldimethylsiloxy)phenol | C12H20O2Si | 108534-47-0 | Details |
3-(Oxiran-2-ylmethyl)oxolane | C7H12O2 | 1551669-96-5 | Details |
PCMTD1 antibody | Details |
Chlorpropamide | C10H13ClN2O3S | 94-20-2 | Details |
2-Bromo-3-hydroxyisonicotinic acid | C6H4BrNO3 | 1196152-10-9 | Details |
4-Benzyloxan-4-amine hydrochloride | C12H18ClNO | 1385696-59-2 | Details |
N-[4-(dimethylamino)phenyl]-1-phenylcyclopentane-1-carboxamide | C20H24N2O | 1022645-65-3 | Details |
Tau antibody (Thr231) | Details |
5-[(2-Amino-1,3-thiazol-4-yl)methyl]-4-(prop-2-en-1-yl)-4H-1,2,4-triazole-3-thiol | C9H11N5S2 | 690643-10-8 | Details |
Normal Chicken Serum | Details |
Bisaboloxide A | C15H26O2 | 22567-36-8 | Details |
tert-Butyl 8-amino-2-azabicyclo[5.1.0]octane-2-carboxylate | C12H22N2O2 | 2155852-87-0 | Details |
4-Chloro-2-cyclopropyl-5-methoxy-6-methylpyrimidine | C9H11ClN2O | 1803603-32-8 | Details |
Methyl N-(azetidin-3-yl)carbamate hydrochloride | C5H11ClN2O2 | 1803610-94-7 | Details |
[3-Methyl-4-(morpholin-4-yl)phenyl]methanol | C12H17NO2 | 678148-51-1 | Details |
8-Aminoadenosine-5'-triphosphate sodium salt - 10mM aqueous solution | C10H17N6O13P3 | 35874-49-8 | Details |
rac-(1R,2R)-1,2-Dimethylcyclobutane-1,2-dicarboxylic acid | C8H12O4 | 23472-39-1 | Details |
4-(1,3-Dioxaindan-5-ylmethylidene)-2-tert-butyl-1,2,3,4-tetrahydroacridine-9-carboxylic acid | C26H25NO4 | 647036-25-7 | Details |
1-methylisatin, 3-thiosemicarbazide | C10H10N4OS | 26153-15-1 | Details |
4-{[(3-Methyl-1,2,4-oxadiazol-5-yl)methyl]sulfanyl}benzoic acid | C11H10N2O3S | 929973-36-4 | Details |
4-[(1-Methyl-1H-pyrazol-4-yl)methoxy]phenol | C11H12N2O2 | 1152531-66-2 | Details |
H-YTIAALLSPYSYSTTAVVTNPK^-OH | Details |
3-(Piperidin-2-yl)piperidine-2,6-dione hydrochloride | C10H16N2O2.ClH | 2305252-96-2 | Details |
(4-Acetyl-3,5-dimethyl-pyrazol-1-yl)-acetic acid | C9H12N2O3 | 890092-87-2 | Details |
6-(Methoxymethyl)bicyclo[3.1.0]hexan-2-one | C8H12O2 | 1803594-61-7 | Details |
INSRR antibody | Details |
1-O-Acetyl-2,3,4,6-tetra-O-benzyl-b-D-galactopyranose | C36H38O7 | 3866-62-4 | Details |
N1,N5,N10-(E)-Tri-p-coumaroylspermidine | C37H43N3O9 | 364368-18-3 | Details |
6-(Benzylamino)pyridine-3-carbonitrile | C13H11N3 | 15871-91-7 | Details |
2,2-Dimethyltetradecanoic acid | C16H32O2 | 85216-66-6 | Details |
Methyl 3-mercaptobenzoate | C8H8O2S | 72886-42-1 | Details |
NG,NG'-Dimethyl-L-arginine dihydrochloride | C8H19ClN4O2 | 1018960-53-6 | Details |
4-(1,2,3,4-Tetrahydroquinazolin-2-yl)phenol | C14H14N2O | 501446-96-4 | Details |
tert-Butyl 4-(aminomethyl)-3-methylpiperidine-1-carboxylate | C12H24N2O2 | 1236121-41-7 | Details |
imidazo[1,5-a]pyrimidine-8-carboxylate lithium (I) | C7H6LiN3O2 | 1909309-42-7 | Details |
4-(Furan-2-carbonyl)-3-methylpiperazin-2-one | C10H12N2O3 | 1103994-40-6 | Details |
Ethyl 8-bromo-4-chloro-1,6-naphthyridine-3-carboxylate | C11H8BrClN2O2 | 1259065-16-1 | Details |
(3-Cyclopropyl-6-methylpyridazin-4-yl)methanol | C9H12N2O | 2137578-49-3 | Details |
2,3,4,6-Tetra-O-pivaloyl-b-D-galactopyranosyl amine | C26H45NO9 | 108342-87-6 | Details |
H-Pro-Ser-Hyp-Gly-Asp-Trp-OH | C30H39N7O11 | 163722-91-6 | Details |
PAICS Blocking Peptide | Details |
Dihydro daidzein | C15H12O4 | 17238-05-0 | Details |
HNRPF antibody | Details |
3-Ethyloxolan-3-amine hydrochloride | C6H14ClNO | 1799438-60-0 | Details |
Methyl 5-amino-5-phenylpentanoate hydrochloride | C12H18ClNO2 | 1803594-13-9 | Details |
1-Methyl-1H,1aH,6H,6aH-cyclopropa[A]indene-1-carboxylic acid | C12H12O2 | 1803570-83-3 | Details |
3-(5-Methyl-1H-1,2,4-triazol-1-yl)aniline | 1368568-21-1 | Details |
Ac-SLGRKIQI-NH2 | Details |
CMV protein (nuclear) | Details |
3-Geranyloxy-6-methyl-1,8-dihydroxyanthraquinone | Details |
4-(Bromomethyl)phenyl fluoranesulfonate | C7H6BrFO3S | 2123483-82-7 | Details |
Product Total: Product Page: | ||||
41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 |